993 related articles for article (PubMed ID: 17471348)
1. Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis).
Azar DT
Trans Am Ophthalmol Soc; 2006; 104():264-302. PubMed ID: 17471348
[TBL] [Abstract][Full Text] [Related]
2. Expression of angiogenesis-related factors in human corneas after cultivated oral mucosal epithelial transplantation.
Chen HC; Yeh LK; Tsai YJ; Lai CH; Chen CC; Lai JY; Sun CC; Chang G; Hwang TL; Chen JK; Ma DH
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5615-23. PubMed ID: 22850415
[TBL] [Abstract][Full Text] [Related]
3. Novel aspects of corneal angiogenic and lymphangiogenic privilege.
Ellenberg D; Azar DT; Hallak JA; Tobaigy F; Han KY; Jain S; Zhou Z; Chang JH
Prog Retin Eye Res; 2010 May; 29(3):208-48. PubMed ID: 20100589
[TBL] [Abstract][Full Text] [Related]
4. Membrane type-1 matrix metalloproteinase potentiates basic fibroblast growth factor-induced corneal neovascularization.
Onguchi T; Han KY; Chang JH; Azar DT
Am J Pathol; 2009 Apr; 174(4):1564-71. PubMed ID: 19264910
[TBL] [Abstract][Full Text] [Related]
5. Corneal neovascularization after excimer keratectomy wounds in matrilysin-deficient mice.
Kure T; Chang JH; Kato T; Hernández-Quintela E; Ye H; Lu PC; Matrisian LM; Gatinel D; Shapiro S; Gosheh F; Azar DT
Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):137-44. PubMed ID: 12506066
[TBL] [Abstract][Full Text] [Related]
6. MT1-MMP modulates bFGF-induced VEGF-A expression in corneal fibroblasts.
Han KY; Fahd DC; Tshionyi M; Allemann N; Jain S; Chang JH; Azar DT
Protein Pept Lett; 2012 Dec; 19(12):1334-9. PubMed ID: 22670674
[TBL] [Abstract][Full Text] [Related]
7. Expression of integrins and MMPs during alkaline-burn-induced corneal angiogenesis.
Zhang H; Li C; Baciu PC
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):955-62. PubMed ID: 11923234
[TBL] [Abstract][Full Text] [Related]
8. MT1-MMP cleavage of the antiangiogenic proteoglycan decorin: role in corneal angiogenesis.
Mimura T; Chang JH; Kim TI; Onguchi T; Kojima T; Sakimoto T; Azar DT
Cornea; 2011 Oct; 30 Suppl 1(Suppl 1):S45-9. PubMed ID: 21912230
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of corneal neovascularization with plasmid pigment epithelium-derived factor (p-PEDF) delivered by synthetic amphiphile INTeraction-18 (SAINT-18) vector in an experimental model of rat corneal angiogenesis.
Kuo CN; Yang LC; Yang CT; Lai CH; Chen MF; Chen CY; Chen CH; Wu PC; Kou HK; Chen YJ; Hung CH; Tsai CB
Exp Eye Res; 2009 Nov; 89(5):678-85. PubMed ID: 19596319
[TBL] [Abstract][Full Text] [Related]
10. Genetic ablation of CD36 induces age-related corneal neovascularization.
Mwaikambo BR; Sennlaub F; Ong H; Chemtob S; Hardy P
Cornea; 2008 Oct; 27(9):1037-41. PubMed ID: 18812768
[TBL] [Abstract][Full Text] [Related]
11. Corneal neovascularization.
Chang JH; Gabison EE; Kato T; Azar DT
Curr Opin Ophthalmol; 2001 Aug; 12(4):242-9. PubMed ID: 11507336
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of rat corneal angiogenesis by 16-kDa prolactin and by endogenous prolactin-like molecules.
Dueñas Z; Torner L; Corbacho AM; Ochoa A; Gutiérrez-Ospina G; López-Barrera F; Barrios FA; Berger P; Martínez de la Escalera G; Clapp C
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2498-505. PubMed ID: 10509642
[TBL] [Abstract][Full Text] [Related]
13. Corneal Mesenchymal Stromal Cells Are Directly Antiangiogenic via PEDF and sFLT-1.
Eslani M; Putra I; Shen X; Hamouie J; Afsharkhamseh N; Besharat S; Rosenblatt MI; Dana R; Hematti P; Djalilian AR
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5507-5517. PubMed ID: 29075761
[TBL] [Abstract][Full Text] [Related]
14. PEDF-derived peptide inhibits corneal angiogenesis by suppressing VEGF expression.
Matsui T; Nishino Y; Maeda S; Yamagishi S
Microvasc Res; 2012 Jul; 84(1):105-8. PubMed ID: 22386653
[TBL] [Abstract][Full Text] [Related]
15. Pigment epithelium-derived factor is a substrate for matrix metalloproteinase type 2 and type 9: implications for downregulation in hypoxia.
Notari L; Miller A; Martínez A; Amaral J; Ju M; Robinson G; Smith LE; Becerra SP
Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2736-47. PubMed ID: 16043845
[TBL] [Abstract][Full Text] [Related]
16. MT1-MMP-mediated cleavage of decorin in corneal angiogenesis.
Mimura T; Han KY; Onguchi T; Chang JH; Kim TI; Kojima T; Zhou Z; Azar DT
J Vasc Res; 2009; 46(6):541-50. PubMed ID: 19571574
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of corneal neovascularization with the combination of bevacizumab and plasmid pigment epithelium-derived factor-synthetic amphiphile INTeraction-18 (p-PEDF-SAINT-18) vector in a rat corneal experimental angiogenesis model.
Kuo CN; Chen CY; Chen SN; Yang LC; Lai LJ; Lai CH; Chen MF; Hung CH; Chen CH
Int J Mol Sci; 2013 Apr; 14(4):8291-305. PubMed ID: 23591843
[TBL] [Abstract][Full Text] [Related]
18. Delayed neovascularization in inflammation-induced corneal neovascularization in interleukin-10-deficient mice.
Samolov B; Kvanta A; van der Ploeg I
Acta Ophthalmol; 2010 Mar; 88(2):251-6. PubMed ID: 19053961
[TBL] [Abstract][Full Text] [Related]
19. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
Ma X; Ottino P; Bazan HE; Bazan NG
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
[TBL] [Abstract][Full Text] [Related]
20. In vitro antiangiogenic activity in ex vivo expanded human limbocorneal epithelial cells cultivated on human amniotic membrane.
Ma DH; Yao JY; Yeh LK; Liang ST; See LC; Chen HT; Lin KY; Liang CC; Lin KK; Chen JK
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2586-95. PubMed ID: 15277481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
